Quigley, Neil Gerard
Steiger, Katja
Hoberück, Sebastian
Czech, Norbert
Zierke, Maximilian Alexander
Kossatz, Susanne
Pretze, Marc
Richter, Frauke
Weichert, Wilko
Pox, Christian
Kotzerke, Jörg
Notni, Johannes http://orcid.org/0000-0002-3964-3391
Funding for this research was provided by:
deutsche forschungsgemeinschaft (SFB 824, SFB 824)
Universitätsklinikum Essen
Article History
Received: 14 July 2021
Accepted: 5 September 2021
First Online: 24 September 2021
Change Date: 25 February 2022
Change Type: Update
Change Details: The original version of this paper was updated to add the missing compact agreement Open Access funding note.
Declarations
:
: Procedures involving laboratory mice and their care were conducted in conformity with institutional guidelines and with approval from the responsible local authorities (Regierung von Oberbayern, ROB-55.2–2532.Vet_2-18–109).
: The authors affirm that the patients provided written informed consent prior to the investigations.
: The authors affirm that the patients provided written informed consent for publication of data and images.
: N.G.Q., K.S., and J.N. are co-inventors of patents related to <sup>68</sup> Ga-Trivehexin. J.N. is shareholder of TRIMT GmbH (Radeberg, Germany), which is active in the field of radiopharmaceutical develeopment.